What Is the Economic Impact of Delaying Kidney Replacement Therapy Through Ketoanalogue-Supplemented Low Protein Diet in Advanced Chronic Kidney Disease?

Author(s)

Praditpornsilpa K1, Garneata L2, Lin YC3, Povero M4, Pradelli L5, Susantitaphong P1, Wu CH6
1King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 2“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Bucharest, Romania, 3Taipei Medical University, Taipei, Taiwan, 4AdRes HEOR, Torino, Italy, 5AdRes HEOR, Turin, Italy, 6Taipei Tzu Chi Hospital, Taipei, Taiwan

Presentation Documents

The prevalence of Chronic Kidney Disease (CKD) is rising globally causing a significant burden to healthcare systems. Especially in low- and middle-income countries, nephrologists and governments face the challenge of providing quality and cost-effective kidney replacement therapy (KRT) -hemodialysis, peritoneal dialysis, or transplantation. The length of time in late CKD and time to initiate dialysis is of significance as it influences cost-effectiveness decisions. Currently, no treatment options are available for restoring kidney function.

OBJECTIVES: A vegetarian very low-protein diet supplemented with ketoanalogues of essential amino acids (sVLPD) delays dialysis initiation in CKD patients. In this cost-effectiveness analysis, we compare an sVLPD with a conventional low-protein diet (LPD) in patients with CKD stage 4–5 using data from Taiwan and Thailand.

METHODS: Markov model simulated health outcomes and care costs in patients receiving an sVLPD (0.3–0.4 g/kg-day, vegetarian diet) supplemented with ketoanalogues. Health state transition probabilities and resource cost inputs were based on published literature and local sources, respectively.

RESULTS: sVLPD increased survival and quality-adjusted life years (QALYs) at a lower cost than LPD. Total cost of care in Taiwan was 2,262,592.30 NTD (68,059.35 EUR) with an LPD and 1,096,938.20 NTD (32,996.18 EUR) with an sVLPD (difference, –1,165,654.10 NTD; –35,063.17 EUR). Total cost of care in Thailand was 500,731.09 THB (14,584.12 EUR) with an LPD and 421,019.22 THB (12,262.46 EUR) with an sVLPD (difference, –79,711.86 THB; –2,321.66 EUR).

CONCLUSIONS: A ketoanalogue-supplemented vegetarian VLPD increases QALYs is cost saving versus LPD in pre-dialysis CKD patients in Taiwan and Thailand. These data, together with the KDOQI Guidelines for nutrition in CKD, support dietary intervention using ketoanalogue-supplemented vegetarian VLPDs to prevent CKD progression and postpone dialysis as a cost-effective approach, with beneficial effects for patients and healthcare providers.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

EE225

Topic

Economic Evaluation, Study Approaches

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis, Decision Modeling & Simulation

Disease

SDC: Urinary/Kidney Disorders, STA: Nutrition

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×